According to Sun Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $5.64 B. In 2022 the company made a revenue of $5.25 B an increase over the years 2021 revenue that were of $5.05 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $5.64 B | 7.48% |
2022 | $5.25 B | 3.97% |
2021 | $5.05 B | 14.54% |
2020 | $4.41 B | -1.23% |
2019 | $4.46 B | 8.61% |
2018 | $4.11 B | 1.61% |
2017 | $4.04 B | -11.91% |
2016 | $4.59 B | 11.9% |
2015 | $4.10 B | -0.07% |
2014 | $4.11 B | 63.61% |
2013 | $2.51 B | 28.18% |
2012 | $1.95 B |